Testosterone, thrombophilia, thrombosis

Blood Coagulation and Fibrinolysis

Volumn 25, Issue 7, 2014, Pages 683-687

  Glueck, Charles J ^a   Friedman, Joel ^a   Hafeez, Ahsan ^a   Hassan, Atif ^a   Wanga, Ping ^a  

^a JEWISH HOSPITAL   (United States)

Author keywords

Deep venous thrombosis; Pulmonary embolus; Testosterone; Thrombophilia; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN S; PROTHROMBIN; TESTOSTERONE; WARFARIN;

ADULT; ANDROGEN THERAPY; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING DISORDER; BONE NECROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HETEROZYGOSITY; HIP OSTEONECROSIS; HOMOZYGOSITY; HUMAN; HYPOFIBRINOLYSIS; KNEE OSTEONECROSIS; LUNG EMBOLISM; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECURRENT DISEASE; SPINAL CORD INFARCTION; SPINAL CORD INJURY; THROMBOPHILIA; AGED; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED; PATHOPHYSIOLOGY; THROMBOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION DISORDERS; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; TESTOSTERONE; THROMBOPHILIA; THROMBOSIS;

EID: 84927689239     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000126     Document Type: Article

References (37)

1. Glueck CJ, Richardson-Royer C, Schultz R, Burger T, Bowe D, Padda J, et al. Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory, hypothesis-generating study. Clin Appl Thromb Hemost 2014; 20:244-249.
2. Glueck CJ, Richardson-Royer C, Schultz R, Burger T, Labitue F, Riaz MK, et al. Testosterone, thrombophilia, and thrombosis. Clin Appl Thromb Hemost 2014; 20:22-30.
3. Glueck CJ, Bowe D, Valdez A, Wang P. Thrombosis in three postmenopausal women receiving testosterone therapy for low libido. Womens Health (Lond Engl) 2013; 9:405-410.
4. Glueck CJ, Goldenberg N, Budhani S, Lotner D, Abuchaibe C, Gowda M, et al. Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia. Transl Res 2011; 158:225-234.
5. Pandit RS, Glueck CJ. Testosterone, anastrozole, factor V Leiden heterozygosity and osteonecrosis of the jaws. Blood Coagul Fibrinolysis 2014; 25:286-288.
6. Fanikos J, Rao A, Seger AC, Carter D, Piazza G, Goldhaber SZ. Hospital costs of acute pulmonary embolism. Am J Med 2013; 126:127-132.
7. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004; 89:2085-2098.
8. Baillargeon J, Urban RJ, Ottenbacher KJ, Pierson KS, Goodwin JS. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med 2013; 173:1465-1466.
9. Middeldorp S. Is thrombophilia testing useful? Hematology Am Soc Hematol Educ Program 2011; 2011:150-155.
10. Roldan V, Lecumberri R, Munoz-Torrero JF, Vicente V, Rocha E, Brenner B, et al. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res 2009; 124:174-177.
11. Kvasnicka J, Hajkova J, Bobcikova P, Kvasnicka T, Duskova D, Poletinova S, et al. Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-14G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay). Cas Lek Cesk 2012; 151:76-82.
12. Balasa VV, Gruppo RA, Glueck CJ, Stroop D, Becker A, Pillow A, et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost 1999; 81:739-744.
13. Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin Appl Thromb Hemost 2005; 11:375-389.
14. Glueck CJ, Pranikoff J, Aregawi D, Haque M, Zhu B, Tracy T, et al. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage. Metabolism 2005; 54:1345-1349.
15. Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism 1993; 42:236-246.
16. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res 2001; 386:19-33.
17. de Visser MC, van Minkelen R, van Marion V, den Heijer M, Eikenboom J, Vos HL, et al. Genome-wide linkage scan in affected sibling pairs identifies novel susceptibility region for venous thromboembolism: genetics in familial thrombosis study. J Thromb Haemost 2013; 11:1474-1484.
18. Zhou X, Qian W, Li J, Zhang P, Yang Z, Chen W, et al. Who are at risk for thromboembolism after arthroplasty? A systematic review and metaanalysis. Thromb Res 2013; 132:531-536.
19. Gomez-Puerta JA, Peris P, Reverter JC, Espinosa G, Martinez-Ferrer A, Monegal A, et al. High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature. Medicine (Baltimore) 2013; 92:295-304.
20. Simsek E, Yesilyurt A, Pinarli F, Eyerci N, Ulus AT. Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence. Gene 2014; 536:171-176.
21. Glueck CJ, Pranikoff J, Khan N, Riaz K, Chavan K, Raj P, et al. High factor XI, recurrent pregnancy loss, enoxaparin. Fertil Steril 2010; 94:2828-2831.
22. Balta G, Altay C, Gurgey A. PAI-1 gene 4G/5G genotype: a risk factor for thrombosis in vessels of internal organs. Am J Hematol 2002; 71:89-93.
23. Jeon YJ, Kim YR, Lee BE, Choi YS, Kim JH, Shin JE, et al. Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women. Thromb Haemost 2013; 110:742-750.
24. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 2002; 99:333-341.
25. L'Vova OA, Kovtun OP, Chegodaev DA. Gene-determined hemocoagulation disease as a cause of ischemic stroke in children. Zh Nevrol Psikhiatr Im S S Korsakova 2011; 111:3-9.
26. Kupeli E, Verdi H, Simsek A, Atac FB, Eyuboglu FO. Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis. Clin Appl Thromb Hemost 2011; 17:E87-E94.
27. Hussein AS. High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T. J Thromb Thrombolysis 2012; 34:383-387.
28. Tam WH, Ng MH, Yiu AK, Lau KM, Cheng GY, Li CY. Thrombophilia among Chinese women with venous thromboembolism during pregnancy. Gynecol Obstet Invest 2012; 73:183-188.
29. Signorelli SS, Fiore V, Puccia G, Mastrosimone G, Anzaldi M. Thrombophilia in patients with lower limbs deep veins thrombosis (LDVT) results of a monocentric survey on 103 consecutive outpatients. Clin Appl Thromb Hemost 2013; epub, Jan 29.
30. Finkelstein JS, Yu EW, Burnett-Bowie SA. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 2013; 369:2457.
31. Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology 2005; 64:290-296.
32. Vigen R, O'Donnell CL, Baron AE, Grunwald GK, Maddox TM, Bradley SM, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013; 310:1829-1836.
33. Ruige JB, Ouwens DM, Kaufman JM. Beneficial and adverse effects of testosterone on the cardiovascular system in men. J Clin Endocrinol Metab 2013; 98:4300-4310.
34. Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab 2012; 97:2050-2058.
35. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363:109-122.
36. Xu L, Freeman G, Cowling BJ, Schooling CM. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med 2013; 11:108.
37. Finkle WD, Greenland S, Ridgeway GK, Adams JL, Frasco MA, Cook MB, et al. Increased risk of nonfatal myocardial infarction following testosterone therapy prescription in men. PLoS One 2014; 9:e85805.